Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
08/2007
08/01/2007EP1812440A1 PYRAZOLOÝ1,5-a¨PYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES
08/01/2007EP1812424A2 Kinase inhibitors
08/01/2007EP1812409A1 Aminoquinazolines compounds
08/01/2007EP1811844A1 Methods for diagnosis and treatment of cancer
08/01/2007EP1187592B1 Alpha v integrin receptor antagonists
08/01/2007EP1018879B1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
08/01/2007CN1329407C Method for synthesizing beta-L-5-fluoro-2',3'-dideoxy-2',3'-didehydrocytidine
08/01/2007CN1329032C Non-sedating barbiturate compounds as neuroprotective agents
08/01/2007CN101010318A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
08/01/2007CN101010317A 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
08/01/2007CN101010304A Molecular chaperone function regulator
08/01/2007CN101010303A Quinazolinone derivatives and their use as B-RAF inhibitors
08/01/2007CN101010299A Six-membered heterocycles useful as serine protease inhibitors
08/01/2007CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/01/2007CN101007784A Antibacterial agents
07/2007
07/31/2007US7250516 Phenylalanine derivatives
07/31/2007US7250511 intermediates in the preparation of derivatives which possess anti-cancer activity; synthesis of 4{N-[(6RS)-2-Methyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl]-N-(prop-2-ynyl)amino}benzoic acid
07/31/2007US7250421 Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
07/31/2007US7250419 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
07/31/2007US7250418 Corticotropin releasing factor antagonist; antiinflammatory agents; drug abuse; analgesics; antihistamines; skin disorders; neurodegenerative disease; eating disorders;eating disorders; antiepileptic agents; cardiovascular disorders
07/31/2007CA2175212C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
07/31/2007CA2121253C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
07/26/2007WO2007082880A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
07/26/2007WO2007082876A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
07/26/2007WO2007082874A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
07/26/2007WO2007082434A1 Quinazoline derivatives,preparation methods and uses thereof
07/26/2007WO2007056124A3 Compounds for modulating trpv3 function
07/26/2007WO2007031208A3 A use of sulfonanilides as herbicide
07/26/2007WO2006127588A3 Modulators of atp-binding cassette transporters
07/26/2007US20070173641 Azotization of 5-amino-3-t-butyl-4-cyanopyrazole, then reacting with couplers and alkylation or arylation, to form azo dyes, used as inks having colorfastness; liquid crystal displays and plasma display panels; excellent color reproducibility
07/26/2007US20070173520 stable dosage form of 5-methyl-pyridine-2-sulfonic acid [6-methoxy-5-(2-methoxy-phenoxy)-2-pyridin-4-yl-pyrimidin-4-yl]-amide, used for treatment of cardiovascular disorders
07/26/2007US20070173498 Melanin concentrating hormone antagonist
07/26/2007CA2633100A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
07/26/2007CA2631874A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
07/26/2007CA2630717A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
07/25/2007EP1810970A1 Therapeutic piperazine compounds
07/25/2007EP1809611A1 Reversed pyrimidinone compounds as calcilytics
07/25/2007EP1809610A1 Production method of pyrimidine compounds
07/25/2007EP1809609A1 Process for the production of pyrimidine-5-carboxylates
07/25/2007EP1809608A1 Pyrimidine and quinoline potentiators of metabotropic glutamate receptors
07/25/2007EP1809290A2 Pyrimidine derivatives as ion channel modulators and methods of use
07/25/2007EP1809288A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
07/25/2007EP1709010B1 Method for producing 2-amino-4,6-dichloro-5-formamidopyrimidine
07/25/2007EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2007EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands
07/25/2007CN1328261C Uracil compounds and their use
07/25/2007CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
07/25/2007CN1328246C Butyl benzene orthobenzol diacid amide derivative or its salt, garderning pesticide and its application method
07/25/2007CN101006088A Fused pyrimidine derivatives and compositions thereof as CXCR3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases
07/25/2007CN101006079A 嘧啶衍生物 Pyrimidine derivatives
07/25/2007CN101006049A Optically active phthalamide derivative, insecticide for agriculture and horticulture and use thereof
07/25/2007CN101005842A Modulators of muscarinic receptors
07/25/2007CN101003515A 4-anilino quinazoline derivatives as antiproliferative agents
07/25/2007CN101003514A Derivative of quinazoline, preparation method and usage
07/25/2007CN101003513A Compound in quinazoline class or its pharmaceutical salt preparation method, and medical usage
07/25/2007CN101003512A Method for preparing methylamino uracil
07/25/2007CN101003511A Method for preparing 2 ¿C amido ¿C 4,6 ¿C dichloro ¿Cformamido pyrimidines
07/24/2007US7247756 1,4-disubstituted benzenes as insecticides
07/24/2007US7247633 Pyrimidine compounds and their use
07/24/2007CA2479846C Phosphonomethoxymethylpurine/pyrimidine derivatives
07/19/2007WO2007082076A1 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides
07/19/2007WO2007080382A1 Morpholino pyrimidine derivatives and their use in therapy
07/19/2007WO2007079869A2 Cyclic aminals as fragrances
07/19/2007US20070167625 Preparation of rosuvastatin
07/19/2007US20070167624 Process for preparing 1-methoxymethyl 5,5-diphenybarbituric acid
07/19/2007US20070167621 Substituted pyrimidinones
07/19/2007US20070167472 2-Methoxy-ethanesulfamic acid [6-[2-(5-bromo-pyrimidin-2-yloxy)-ethoxy]-5-(2-chloro-5-methoxy-phenoxy)-pyrimidin-4-yl]-amide; vasoconstrictor, mediator of cardiac, renal, endocrine functions; neurotransmitter release, activation of inflammatory cells, fibrosis, cell proliferation and differentiation
07/19/2007US20070167471 Substituted quinazoline compounds useful as p38 kinase inhibitors
07/19/2007US20070167459 Nitrogen-containing heterocyclic compounds and medicinal use thereof
07/19/2007US20070167451 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES
07/19/2007US20070167421 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
07/19/2007US20070167377 Inhibitors of glycinamide ribonucleotide transformylase
07/19/2007CA2635997A1 Morpholino pyrimidine derivatives and their use in therapy
07/19/2007CA2626018A1 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides
07/18/2007EP1807402A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives
07/18/2007EP1807401A1 Process for the preparation of phenyl 2-pyrimidinyl ketones and their novel intermediates
07/18/2007EP1807392A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor
07/18/2007EP1807391A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
07/18/2007EP1725239B1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
07/18/2007EP1509537B1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
07/18/2007EP1373224B1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
07/18/2007CN1326841C Arylalkane-sulfonamides having endothelin-antagonist activity
07/18/2007CN1326569C Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative
07/18/2007CN101001862A Tricyclic compounds and their use as MGLUR1 antagonists
07/18/2007CN101001846A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
07/18/2007CN101001845A Substituted quinazolones as anti-cancer agents.
07/18/2007CN100999343A Oxygen scavenger and boiler water treatment chemical
07/18/2007CN100999342A Oxygen scavenger and boiler water treatment chemical
07/17/2007US7244844 Reference standard for characterization of rosuvastatin
07/17/2007US7244776 Benzoxazinone, oxanilide, benzylidene malonate, quinazoline and benzotriazole derivatives; polymer and photographic stabilizers
07/17/2007US7244738 Urogenital disorders; sexual diosrders; benign prostatic hyperplasia; analgesics
07/17/2007US7244737 Process for the preparation of azoxystrobin and analogues thereof
07/17/2007US7244735 useful for treating cancer, neurological disorders, autoimmune disorders, and other diseases that are alleviated by protein kinase inhibitors
07/17/2007US7244692 Substituted benzoylcyclohexane diones for use as herbicides
07/17/2007CA2373944C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
07/12/2007WO2007079404A2 Drug-polymer conjugates
07/12/2007WO2007079199A2 Substituted bis-amide metalloprotease inhibitors
07/12/2007WO2007022366B1 Rosuvastatin calcium with a low salt by-product content
07/12/2007WO2006058201A3 Heterocyclic and bicyclic compounds, compositions and methods
07/12/2007WO2006029075A3 Fibrate compounds having ppar agonist activity